IGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells

類似資料

• Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment
  著者:: Demuth, Christina, 等
  出版事項: (2017)
• MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells
  著者:: Jakobsen, K R, 等
  出版事項: (2017)
• Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells
  著者:: Clement, Michelle Simone, 等
  出版事項: (2020)
• The role of epithelial to mesenchymal transition in resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
  著者:: Jakobsen, Kristine Raaby, 等
  出版事項: (2016)
• The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment
  著者:: Demuth, Christina, 等
  出版事項: (2018)